Guest Contributor


Organizations:
DLVR Therapeutics Inc, Intellectual Property Development and Commercialization, Ontario Institute for Cancer Research, and TORCell Therapeutics Inc

OICR spins offs to develop promising technologies

Guest Contributor
May 24, 2011



... Please become a Member or login to read the rest of this article ...


Other News

MITACS restructures as NCE funding winds down

RSC to develop strategic and financial plans

Bioniche opens animal vaccine production facility

MedBioGene licenses technology to Precision






Events For Leaders in
Science, Tech, Innovation, and Policy


Discuss and learn from those in the know at our virtual and in-person events.



See Upcoming Events










You have 0 free articles remaining.
Don't miss out - start your free trial today.

Start your FREE trial    Already a member? Log in






Top

By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.